Boston Research & Management’s Accenture ACN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.51M | Sell |
17,696
-612
| -3% | -$143K | 0.83% | 53 |
|
|
2025
Q4 | $4.91M | Sell |
18,308
-1,546
| -8% | -$393K | 1.13% | 38 |
|
|
2025
Q3 | $4.9M | Buy |
19,854
+798
| +4% | +$208K | 1.08% | 40 |
|
|
2025
Q2 | $5.7M | Buy |
19,056
+501
| +3% | +$153K | 1.36% | 30 |
|
|
2025
Q1 | $5.79M | Buy |
18,555
+16
| +0.1% | +$5.65K | 1.44% | 25 |
|
|
2024
Q4 | $6.52M | Sell |
18,539
-51
| -0.3% | -$18.4K | 1.6% | 22 |
|
|
2024
Q3 | $6.57M | Buy |
18,590
+188
| +1% | +$61.8K | 1.54% | 23 |
|
|
2024
Q2 | $5.58M | Buy |
18,402
+608
| +3% | +$186K | 1.41% | 25 |
|
|
2024
Q1 | $6.17M | Sell |
17,794
-29
| -0.2% | -$10.6K | 1.52% | 23 |
|
|
2023
Q4 | $6.25M | Buy |
17,823
+370
| +2% | +$119K | 1.66% | 22 |
|
|
2023
Q3 | $5.36M | Buy |
17,453
+170
| +1% | +$53.6K | 1.58% | 22 |
|
|
2023
Q2 | $5.33M | Buy |
17,283
+188
| +1% | +$54.6K | 1.51% | 24 |
|
|
2023
Q1 | $4.88M | Buy |
17,095
+906
| +6% | +$247K | 1.46% | 24 |
|
|
2022
Q4 | $4.32M | Buy |
16,189
+643
| +4% | +$178K | 1.34% | 33 |
|
|
2022
Q3 | $4M | Buy |
15,546
+408
| +3% | +$118K | 1.36% | 33 |
|
|
2022
Q2 | $4.2M | Buy |
15,138
+105
| +0.7% | +$31.6K | 1.36% | 34 |
|
|
2022
Q1 | $5.07M | Sell |
15,033
-6,823
| -31% | -$2.3M | 1.47% | 26 |
|
|
2021
Q4 | $9.06M | Sell |
21,856
-277
| -1% | -$101K | 2.47% | 6 |
|
|
2021
Q3 | $7.08M | Sell |
22,133
-350
| -2% | -$114K | 2.11% | 11 |
|
|
2021
Q2 | $6.63M | Sell |
22,483
-1,620
| -7% | -$464K | 2.01% | 13 |
|
|
2021
Q1 | $6.66M | Sell |
24,103
-560
| -2% | -$145K | 2.14% | 11 |
|
|
2020
Q4 | $6.44M | Sell |
24,663
-286
| -1% | -$68.6K | 2.24% | 8 |
|
|
2020
Q3 | $5.64M | Sell |
24,949
-1,260
| -5% | -$289K | 2.2% | 12 |
|
|
2020
Q2 | $5.63M | Sell |
26,209
-119
| -0.5% | -$22.5K | 2.34% | 11 |
|
|
2020
Q1 | $4.3M | Sell |
26,328
-845
| -3% | -$163K | 2.16% | 14 |
|
|
2019
Q4 | $5.72M | Sell |
27,173
-323
| -1% | -$63K | 2.15% | 9 |
|
|
2019
Q3 | $5.29M | Sell |
27,496
-350
| -1% | -$67.7K | 2.09% | 12 |
|
|
2019
Q2 | $5.14M | Sell |
27,846
-385
| -1% | -$69.1K | 2.08% | 12 |
|
|
2019
Q1 | $4.97M | Buy |
28,231
+1,765
| +7% | +$277K | 2.07% | 11 |
|
|
2018
Q4 | $3.73M | Buy |
26,466
+480
| +2% | +$75.9K | 1.78% | 24 |
|
|
2018
Q3 | $4.42M | Sell |
25,986
-130
| -0.5% | -$21.6K | 2.02% | 11 |
|
|
2018
Q2 | $4.27M | Sell |
26,116
-185
| -0.7% | -$28.8K | 2.1% | 9 |
|
|
2018
Q1 | $4.04M | Sell |
26,301
-455
| -2% | -$72.1K | 2.06% | 14 |
|
|
2017
Q4 | $4.1M | Sell |
26,756
-1,335
| -5% | -$193K | 2.05% | 15 |
|
|
2017
Q3 | $3.79M | Sell |
28,091
-90
| -0.3% | -$11.7K | 1.94% | 16 |
|
|
2017
Q2 | $3.48M | Buy |
28,181
+40
| +0.1% | +$4.87K | 1.89% | 18 |
|
|
2017
Q1 | $3.37M | Sell |
28,141
-285
| -1% | -$34K | 1.84% | 20 |
|
|
2016
Q4 | $3.33M | Sell |
28,426
-280
| -1% | -$33.2K | 1.89% | 16 |
|
|
2016
Q3 | $3.51M | Buy |
28,706
+200
| +0.7% | +$22.8K | 2.03% | 12 |
|
|
2016
Q2 | $3.23M | Sell |
28,506
-375
| -1% | -$43.5K | 1.96% | 12 |
|
|
2016
Q1 | $3.33M | Sell |
28,881
-275
| -0.9% | -$28.2K | 2.07% | 10 |
|
|
2015
Q4 | $3.05M | Sell |
29,156
-770
| -3% | -$81.3K | 1.89% | 15 |
|
|
2015
Q3 | $2.94M | Sell |
29,926
-200
| -0.7% | -$19.8K | 1.94% | 13 |
|
|
2015
Q2 | $2.92M | Sell |
30,126
-170
| -0.6% | -$16.2K | 1.85% | 21 |
|
|
2015
Q1 | $2.84M | Buy |
30,296
+345
| +1% | +$30.8K | 1.8% | 22 |
|
|
2014
Q4 | $2.67M | Buy |
29,951
+240
| +0.8% | +$19.9K | 1.68% | 24 |
|
|
2014
Q3 | $2.42M | Buy |
29,711
+2,640
| +10% | +$212K | 1.62% | 26 |
|
|
2014
Q2 | $2.19M | Buy |
27,071
+1,660
| +7% | +$133K | 1.51% | 31 |
|
|
2014
Q1 | $2.02M | Sell |
25,411
-320
| -1% | -$26.3K | 1.49% | 31 |
|
|
2013
Q4 | $2.12M | Buy |
25,731
+2,106
| +9% | +$159K | 1.63% | 28 |
|
|
2013
Q3 | $1.74M | Buy |
23,625
+1,100
| +5% | +$81.4K | 1.47% | 35 |
|
|
2013
Q2 | $1.62M | Buy |
+22,525
| New | +$1.79M | 1.44% | 34 |
|
Other funds holding ACN
VCM
VPM
Boston Research & Management's ACN Position: Q1 2026 in Review
Boston Research & Management reduced its Accenture (ACN) stake by 3.3% in Q1 2026, selling an estimated $143K and leaving 17,696 shares worth $3.51M. The position accounts for 0.83% of the portfolio, ranked #53.
Boston Research & Management first reported a position in ACN in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.06M in Q4 2021. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.
- Boston Research & Management held 17,696 shares of Accenture worth $3.51M as of Q1 2026.
- Boston Research & Management sold 612 Accenture shares in Q1 2026, an estimated $143K.
- Accenture made up 0.83% of Boston Research & Management's portfolio in Q1 2026, its #53 holding.
- Boston Research & Management first reported a position in Accenture in Q2 2013 and has held it in 52 quarters since.
- Boston Research & Management's Accenture position peaked at $9.06M in Q4 2021.
- 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.
Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.